Stockreport

FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo [Yahoo! Finance]

Arvinas, Inc.  (ARVN) 
Last arvinas, inc. earnings: 11/4 05:00 pm Check Earnings Report
PDF It can be inferred that the ODAC thinks the risk of treatment with the Blenrep combo currently appears to outweigh its benefit profile at the proposed dose for treating [Read more]